Sabby Capital is a New Jersey-based investment advisory firm focused on the healthcare industry.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Jun 22, 2015
Ardelyx
|
Post-IPO Equity | $77.77M | Biotechnology | — |
|
Nov 12, 2014
Blueprint Medicines
|
Series C | $50M | Bioinformatics | — |